More on ORIC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ORIC Pharmaceuticals Inc. (NQ:ORIC)
Delayed: 13.71 -0.14 (1.01%)
Prev. Close $13.85  
Open$13.48 
52 Wk High$ 
52 Wk Low$ 
Day High$14.05 
Day Low$13.20 
P/E N/A  
EPS$ 
Volume998,921 

Friends, Peers and Foes (?): ARWR, CELC, KALV TVTX (more...)

Mar 6, 2026 04:30 PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Feb 26, 2026 04:53 PM Form 4 Oric Pharmaceuticals, For: Feb 24 Filed by: Piscitelli Dominic
Feb 25, 2026 06:41 AM ORIC Pharmaceuticals (ORIC) PT Raised to $25 at H.C. Wainwright
Feb 24, 2026 04:10 PM Form 144 Oric Pharmaceuticals, Filed by: Piscitelli Dominic
Feb 24, 2026 05:15 AM ORIC Pharmaceuticals (ORIC) PT Raised to $17 at Citi
Feb 24, 2026 12:34 AM Oppenheimer Reiterates Outperform Rating on ORIC Pharmaceuticals (ORIC)
Feb 23, 2026 05:28 PM ORIC Pharmaceuticals, Inc. (ORIC) Tops Q4 EPS by 7c
Feb 23, 2026 05:06 PM Form 8-K Oric Pharmaceuticals, For: Feb 23
Feb 23, 2026 05:03 PM Form 424B5 Oric Pharmaceuticals,
Feb 23, 2026 04:59 PM Form S-8 Oric Pharmaceuticals,
View All Articles

Entities mentioned with ORIC

View All Entities